Related references
Note: Only part of the references are listed.Identification of USP18 as an Important Regulator of the Susceptibility to IFN-α and Drug-Induced Apoptosis
Harish Potu et al.
CANCER RESEARCH (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Cell-Type Specific Gene Expression Signature in Liver Underlies Response to Interferon Therapy in Chronic Hepatitis C Infection
Limin Chen et al.
GASTROENTEROLOGY (2010)
IL28B Genotype Is Associated With Differential Expression of Intrahepatic Interferon-Stimulated Genes in Patients With Chronic Hepatitis C
Thomas J. Urban et al.
HEPATOLOGY (2010)
Receptor Density Is Key to the Alpha2/Beta Interferon Differential Activities
Ignacio Moraga et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43
Magdalena Sarasin-Filipowicz et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
RNA Interference Screen Identifies Usp18 as a Regulator of Epidermal Growth Factor Receptor Synthesis
Jason E. Duex et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Dendritic cells and cytokines in immune rejection of cancer
Maria Ferrantini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
The basis for selective E1-E2 interactions in the ISG15 conjugation system
Larissa A. Durfee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities
Eyal Kalie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
T. Asselah et al.
GUT (2008)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Comparable potency of IFNα2 and IFNß on immediate JAK/STAT activation but differential down-regulation of IFNAR2
Zrinka Marijanovic et al.
BIOCHEMICAL JOURNAL (2007)
Type III interferon (IFN) induces a type IIFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mtogen-activated protein kinases
Zhangle Zhou et al.
JOURNAL OF VIROLOGY (2007)
Differential receptor subunit affinities of Type I interferons govern differential signal activation
Eva Jaks et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
IL-28 and IL-29: Newcomers to the interferon family
Gilles Uze et al.
BIOCHIMIE (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection
Glenn Randall et al.
GASTROENTEROLOGY (2006)
Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity
Michal Slutzki et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Oxana A. Malakhova et al.
EMBO JOURNAL (2006)
Differential responsiveness to IFN-α and IFN-β of human mature DC through modulation of IFNAR expression
Martina Severa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo
N Ank et al.
JOURNAL OF VIROLOGY (2006)
Inquiring into the differential action of interferons (IFNs):: an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-β
DA Jaitin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling
KI Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice
KP Knobeloch et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Interferon-α and -β differentially regulate osteoclastogenesis:: Role of differential induction of chemokine CXCL11 expression
LFL Coelho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus
A Osiak et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
LM Chen et al.
GASTROENTEROLOGY (2005)
Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells
EM Coccia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
UBP43 (USP18) specifically removes ISG15 from conjugated proteins
MP Malakhov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase
E Dondi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18)
H Schwer et al.
GENOMICS (2000)
Share Paper
